Upadacitinib for moderate-to-severe atopic dermatitis: stratified analysis from three randomized phase 3 trials by key baseline characteristics. J Eur Acad Dermatol Venereol 2023 May 29
Component Ana o 3 versus extract for cashew nut allergy: A diagnostic test accuracy study in adults. Clin Exp Allergy 2023 May 29
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial. Am J Clin Dermatol 2023 May 22
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials. Am J Clin Dermatol 2023 May 17:1-13
Successful tapering of dupilumab in atopic dermatitis patients with low disease activity: a large pragmatic daily practice study from the BioDay registry. Br J Dermatol 2023 May 13
Limited excretion of dupilumab into breastmilk: A case report. J Eur Acad Dermatol Venereol 2023 May 05
Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health. JAAD Int 2023 Jun; 11:137-139
The Treat-to-Target Project in Atopic Dermatitis: One Year On. Acta Derm Venereol 2023 Apr 21; 103:adv5382
Biological tipping point in atopic dermatitis patients treated with different dosing intervals of dupilumab. J Invest Dermatol 2023 Mar 28
Developing integrated care pathways for atopic dermatitis-Challenges and unmet needs. Clin Transl Allergy 2023 Mar; 13(3):e12236
Accidental allergic reactions to food in adolescents and adults: An overview of the factors involved and implications for prevention. Front Allergy 2023; 4:1062049
Investigator Global Assessment for impetiginization in Atopic Dermatitis (IGA impetiginization): Development and initial reliability testing. Br J Dermatol 2023 Mar 22
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis. Allergy 2023 Mar 19
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series. Clin Exp Allergy 2023 May; 53(5):586-589
Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis. Acta Derm Venereol 2023 Mar 08; 103:adv00881